ArticleAntibiotics (Basel, Switzerland)2021

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections.

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.